Table of Contents Author Guidelines Submit a Manuscript
Malaria Research and Treatment
Volume 2013, Article ID 234683, 10 pages
http://dx.doi.org/10.1155/2013/234683
Clinical Study

Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes

1Laboratory for Public Health Research Biotechnologies, University of Yaounde, BP 8094, Yaounde, Centre Region, Cameroon
2Department of Biochemistry, University of Dschang, BP 67, Dschang, West Region, Cameroon
3Universite des Montagnes, BP 208, Bangante, West Region, Cameroon
4Faculty of Science, University of Buea, BP 63, Buea, South West Region, Cameroon

Received 30 June 2013; Revised 15 October 2013; Accepted 29 October 2013

Academic Editor: Polrat Wilairatana

Copyright © 2013 Innocent M. Ali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, Guidelines for the Treatment of Malaria, World Health Organization, Geneva, Switzerland, 2006.
  2. R. W. Snow, C. A. Guerra, A. M. Noor, H. Y. Myint, and S. I. Hay, “The global distribution of clinical episodes of Plasmodium falciparum malaria,” Nature, vol. 434, no. 7030, pp. 214–217, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Attaran, K. I. Barnes, C. Curtis et al., “WHO, the global fund, and medical malpractice in malaria treatment,” The Lancet, vol. 363, no. 9404, pp. 237–240, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. N. J. White, “Antimalarial drug resistance,” Journal of Clinical Investigation, vol. 113, no. 8, pp. 1084–1092, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. P. B. Bloland and M. Ettling, “Making malaria-treatment policy in the face of drug resistance,” Annals of Tropical Medicine and Parasitology, vol. 93, no. 1, pp. 5–23, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Nosten and N. J. White, “Artemisinin-based combination treatment of falciparum malaria,” The American Journal of Tropical Medicine and Hygiene, vol. 77, no. 6, pp. 181–192, 2007. View at Google Scholar · View at Scopus
  7. N. J. White, “Assessment of the pharmacodynamic properties of antimalarial drugs in vivo,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 7, pp. 1413–1422, 1997. View at Google Scholar · View at Scopus
  8. K. I. Barnes, D. N. Durrheim, F. Little et al., “Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa,” PLoS Medicine, vol. 2, no. 11, article e330, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. World Health Organization, Guidelines for the Treatment of Malaria, World Health Organization, Geneva, Switzerland, 2nd edition, 2010, http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf.
  10. R. T. Eastman and D. A. Fidock, “Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria,” Nature Reviews Microbiology, vol. 7, no. 12, pp. 864–874, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Comité Nationale de Lutte Contre le Paludisme, “Cameroon national malaria control programme,” Annual Report, 2006, http://www.minsante.gov.cm. View at Google Scholar
  12. L. K. Basco, V. F. Ngane, M. Ndounga et al., “Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change,” The American Journal of Tropical Medicine and Hygiene, vol. 75, no. 3, pp. 388–395, 2006. View at Google Scholar · View at Scopus
  13. J. L. A. Ndiaye, B. Faye, A. M. Diouf et al., “Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria,” Malaria Journal, vol. 7, article 16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. WHO, Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria, WHO/HTM/RBM/2003.50, World Health Organization, Geneva, Switzerland, 2003.
  15. L. C. Ranford-Cartwright, P. Balfe, R. Carter, and D. Walliker, “Frequency of cross-fertilization in the human malaria parasite Plasmodium falciparum,” Parasitology, vol. 107, part 1, pp. 11–18, 1993. View at Google Scholar · View at Scopus
  16. C. V. Plowe, A. Djimde, M. Bouare, O. Doumbo, and T. E. Wellems, “Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa,” The American Journal of Tropical Medicine and Hygiene, vol. 52, no. 6, pp. 565–568, 1995. View at Google Scholar · View at Scopus
  17. A. Djimdé, O. K. Doumbo, J. F. Cortese et al., “A molecular marker for chloroquine-resistant falciparum malaria,” The New England Journal of Medicine, vol. 344, no. 4, pp. 257–263, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Adjuik, P. Agnamey, A. Babiker et al., “Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial,” The Lancet, vol. 359, no. 9315, pp. 1365–1372, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Dorsey, S. Staedke, T. D. Clark et al., “Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial,” The Journal of the American Medical Association, vol. 297, no. 20, pp. 2210–2219, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Oyakhirome, M. Pötschke, N. G. Schwarz et al., “Artesunate—amodiaquine combination therapy for falciparum malaria in young Gabonese children,” Malaria Journal, vol. 6, article 29, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. Kabanywanyi, A. Mwita, D. Sumari, R. Mandike, K. Mugittu, and S. Abdulla, “Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania,” Malaria Journal, vol. 6, article 146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Guthmann, J. Ampuero, F. Fortes et al., “Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bié provinces, central Angola,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 99, no. 7, pp. 485–492, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. van Vugt, S. Looareesuwan, P. Wilairatana et al., “Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 5, pp. 545–548, 2000. View at Google Scholar · View at Scopus
  24. M. Meremikwu, A. Alaribe, R. Ejemot et al., “Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial,” Malaria Journal, vol. 5, article 43, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Price, J. A. Simpson, P. Teja-Isavatharm et al., “Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria,” Antimicrobial Agents and Chemotherapy, vol. 43, no. 2, pp. 341–346, 1999. View at Google Scholar · View at Scopus
  26. H. Barennes, N. Nagot, I. Valea et al., “A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso,” Tropical Medicine and International Health, vol. 9, no. 4, pp. 438–444, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. R. N. Price, J. A. Simpson, F. Nosten et al., “Factors contributing to anemia after uncomplicated falciparum malaria,” The American Journal of Tropical Medicine and Hygiene, vol. 65, no. 5, pp. 614–622, 2001. View at Google Scholar · View at Scopus
  28. P. A. Phillips-Howard and A. B. Bjorkman, “Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs,” Bulletin of the World Health Organization, vol. 68, no. 4, pp. 493–504, 1990. View at Google Scholar · View at Scopus
  29. P. Olliaro, C. Nevill, J. LeBras et al., “Systematic review of amodiaquine treatment in uncomplicated malaria,” The Lancet, vol. 348, no. 9036, pp. 1196–1201, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Orrell, W. R. J. Taylor, and P. Olliaro, “Acute asymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of amodiaquine and artesunate,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 95, no. 5, pp. 517–518, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. S. G. Staedke, M. R. Kamya, G. Dorsey et al., “Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial,” The Lancet, vol. 358, no. 9279, pp. 368–374, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Brasseur, R. Guiguemde, S. Diallo et al., “Amodiaquine remains effective for treating uncomplicated malaria in West and Central Africa,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 6, pp. 645–650, 1999. View at Google Scholar · View at Scopus
  33. V. Guiyedi, J. Koko, M. B. Akotet et al., “Evaluation of efficacy and tolerance of amodiaquine versus chloroquine in the treatment of uncomplicated malaria outbreak in children of Gabon,” Bulletin de la Societe de Pathologie Exotique, vol. 94, no. 3, pp. 253–257, 2001. View at Google Scholar · View at Scopus
  34. D. Schellenberg, E. Kahigwa, C. Drakeley et al., “The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria,” The American Journal of Tropical Medicine and Hygiene, vol. 67, no. 1, pp. 17–23, 2002. View at Google Scholar · View at Scopus
  35. A. A. Djimdé, B. Fofana, I. Sagara et al., “Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali,” The American Journal of Tropical Medicine and Hygiene, vol. 78, no. 3, pp. 455–461, 2008. View at Google Scholar · View at Scopus